Weekly nab-Paclitaxel+Carboplatin with Radiotherapy as First Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer
Not Applicable
Recruiting
- Conditions
- on-Small-Cell Lung Cancer
- Registration Number
- JPRN-UMIN000031017
- Lead Sponsor
- niversity of Fukui Faculty of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) Taxane and CBDCA are contraindicated for administration. 2) A history of severe drug sensitivity. 3) A history of hypersensitivity to albumin. 4)Interstitial pneumonia or pulmonary fibrosis apparent in chest radiography. 5) Active or duplicated cancer with metachronous or simultaneous, multiple cancers. 6) Pleural effusion, drainage and pericardial effusion required drainage. 7) Have serious complications. 8) Patients with peripheral neuropathy of Grade 2 or higher. 9) HBs antigen positive 10) Pregnant women or women who may be pregnant. 11) A man who is willing to conceive. 12) The doctor in charge judged unsuitable for registration of this exam.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The complete resection rate
- Secondary Outcome Measures
Name Time Method 2 years no relapse survival rate and progression free survival rate for 2 years.